Streetbeat News

Analyst Ratings

DOCU

Citigroup analyst Tyler Radke maintains a Buy rating on DocuSign (NASDAQ:DOCU) and raises the price target from $78 to $81.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:29 pm

TW

Citigroup analyst Christopher Allen maintains a Buy rating on Tradeweb Markets (NASDAQ:TW) and raises the price target from $92 to $100.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:27 pm

MU

Citigroup analyst Christopher Danely maintains a 'Buy' rating on Micron Technology (NASDAQ:MU) and raises the price target from $75 to $85.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:25 pm

AEO

Citigroup analyst Paul Lejuez has maintained a Neutral rating on American Eagle Outfitters (NYSE:AEO) and raised the price target from $17 to $18.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:23 pm

CBAY

CymaBay Therapeutics Inc (NASDAQ:CBAY) announced positive topline results from its Phase 3 RESPONSE study of seladelpar for adult patients with primary biliary cholangitis (PBC). The trial achieved the primary and all key secondary endpoints, supporting advancement to regulatory discussions and filing for regulatory approval with the FDA, the UK Medicines and Healthcare Products Regulatory Agency, and the European Medicines Agency. The company's shares are up 7.16% at $14.80 on the last check Thursday.

Portfolio Pulse from Vandana Singh

September 07, 2023 | 2:20 pm

TMO

Thermo Fisher Scientific's (NYSE:TMO) short percent of float has fallen 16.46% since its last report, with 2.56 million shares sold short, which is 0.66% of all regular shares available for trading. This decrease in short interest could signal a more bullish sentiment towards the stock. Compared to its peers, Thermo Fisher Scientific has less short interest.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:15 pm

PHR

Citigroup analyst Daniel Grosslight maintains a Buy rating on Phreesia (NYSE:PHR) but lowers the price target from $40 to $37.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 2:15 pm

JNJ

Johnson & Johnson's (NYSE:JNJ) short percent of float has risen 232.32% since its last report, with 85.50 million shares sold short, which is 3.29% of all regular shares available for trading. It would take traders 2.31 days to cover their short positions on average. An increase in short interest can signal that investors have become more bearish. However, JNJ's short interest as a percentage of float is less than its peer group average of 4.40%.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:15 pm

SONY

Sony Group's (NYSE:SONY) short percent of float has risen 18.18% since its last report, with 1.66 million shares sold short, which is 0.13% of all regular shares available for trading. This increase in short interest can indicate a bearish market sentiment towards Sony's stock. However, compared to its peers, Sony has less short interest as a percentage of float, with an average of 4.63%.

Portfolio Pulse from Benzinga Insights

September 07, 2023 | 2:15 pm

AAPL

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo discusses trade strategies for SPY, QQQ, AAPL, MSFT, TSLA, and NVDA. The memo provides price levels for these assets based on a proprietary formula that considers price, volume, and options flow. The memo suggests potential bullish and bearish scenarios for each asset and recommends traders to stay alert and adjust their tactics based on the market's pulse.

Portfolio Pulse from RIPS

September 07, 2023 | 2:13 pm